There are 2942 resources available
Tumor Registry Pancreatic Cancer: A national registry for the evaluation of treatment strategies in pancreatic cancer
Presenter: Norbert Marschner
Session: Servier - Joining efforts beyond first-line management in patients with metastatic pancreatic cancer
Resources:
Webcast
IO combinations early or intermediate-stage HCC: Current evidence and ongoing trials
Presenter: Ghassan Abou-Alfa
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
Summary and close
Presenter: Eva Ciruelos
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Continuing a patient's journey after pCR: Evidence-based decision–making
Presenter: Christian Jackisch
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Going beyond medicine in HER2-positive breast cancer
Presenter: Christian Jackisch
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
IO combinations in first-line advanced HCC: Current evidence and ongoing trials
Presenter: Peter Galle
Session: AstraZeneca - Current status and future directions for immunotherapy in hepatocellular carcinoma
Resources:
Webcast
Panel discussion
Presenter: Andrew Wardley
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast
Clinical perspectives on a patient with advanced pancreatic cancer
Presenter: Gilad Vainer
Session: Bayer - Precision medicine in Real-world clinical practice: Perspectives from a multidisciplinary team
Resources:
Webcast
Discussion and closing remarks
Presenter: Jean-Yves Blay
Session: Bayer - Precision medicine in Real-world clinical practice: Perspectives from a multidisciplinary team
Resources:
Webcast
Welcome
Presenter: Bettina Ryll
Session: MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
Resources:
Webcast